Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: A meta-analysis of 13 clinical trials

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Peck, Robert N ^a,b,c   Smart, Luke R ^a,b,c   Beier, Rita ^d   Liwa, Anthony C ^b   Grosskurth, Heiner ^e   Fitzgerald, Daniel W ^c   Schmidt, Bernhard Mw ^f  

^a Bugando Medical Centre   (Tanzania)

^b WEILL BUGANDO SCHOOL OF MEDICINE   (Tanzania)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ACE inhibitors; Black; Blood pressure; Hypertension; Meta analysis; Race; Treatment; White

Indexed keywords

BENAZEPRIL; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

ARTICLE; CAUCASIAN; CLINICAL EVALUATION; DIASTOLIC BLOOD PRESSURE; EUROPE; HUMAN; HYPERTENSION; META ANALYSIS; MONOTHERAPY; NEGRO; OUTCOME ASSESSMENT; RECOMMENDED DRUG DOSE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES;

ADULT; AFRICAN AMERICANS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS AS TOPIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84884539171     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-201     Document Type: Article

References (44)

1. Heart disease and stroke statistics-2012 update: a report from the American heart association. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, et al. Circulation 2012 125 2 e220 22179539
2. Management of high blood pressure in blacks: an update of the international society on hypertension in blacks consensus statement. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH, Hall WD, Jones WE, Kountz DS, Lea JP, Nasser S, Nesbitt SD, Saunders E, Scisney-Matlock M, Jamerson KA, Hypertension 2010 56 780 800 10.1161/HYPERTENSIONAHA.110.152892 20921433
3. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Vander SR, Van Bortel LM, J Hypertens 2011 29 1243 1252 10.1097/HJH.0b013e328346995d 21540748
4. Hypertension prevalence and age-related changes of blood-pressure in semi-nomadic and urban Oromos of Ethiopia. Pauletto P, Caroli M, Pessina AC, Dal Palù C, Eur J Epidemiol 1994 10 159 64 10.1007/BF01730365 7813693 (Pubitemid 24288053)
5. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study. Pauletto P, Puato M, Caroli MG, Casiglia E, Munhambo AE, Cazzolato G, Bittolo Bon G, Angeli MT, Galli C, Pessina AC, Lancet 1996 348 784 8 10.1016/S0140-6736(96)01391-8 8813985 (Pubitemid 26308482)
6. Low prevalence of risk factors for coronary heart disease in rural Tanzania. Swai AB, McLarty DG, Kitange HM, Kilima PM, Tatalla S, Keen N, Chuwa LM, Alberti KG, Int J Epidemiol 1993 22 651 9 10.1093/ije/22.4.651 8225739 (Pubitemid 23247567)
7. Cardiovascular risk factors in Tanzania: a revisit. Njelekela M, Negishi H, Nara Y, Tomohiro M, Kuga S, Noguchi T, Kanda T, Yamori M, Mashalla Y, Jian Liu L, Mtabaji J, Ikeda K, Yamori Y, Acta Trop 2001 79 231 239 10.1016/S0001-706X(01)00134-6 11412807 (Pubitemid 32537792)
8. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. Hendriks ME, Wit FWNM, Roos MTL, Brewster LM, Akande TM, de Beer IH, Mfinanga SG, Kahwa AM, Gatongi P, Van Rooy G, Janssens W, Lammers J, Kramer B, Bonfrer I, Gaeb E, van der Gaag J, Rinke de Wit TF, Lange JMA, Schultsz C, PLos One 2012 7 32638 10.1371/journal.pone.0032638 22427857
9. Hypertension-related admissions and outcome in a tertiary hospital in northeast Nigeria. Kolo PM, Jibrin YB, Sanya EO, Alkali M, Peter Kio IB, Moronkola RK, Int J Hypertens 2012 2012 960546 22778913
10. Disease patterns in the medical wards of a rural South African hospital. Ndjeka N, Ogunbanjo G, S Afr Fam Pract 2003 45 10 11
11. Prevalence of hypertension and its complications among medical admissions at the University of Nigeria Teaching Hospital, Enugu (Study 2). Ike SO, Niger J Med 2009 18 68 72 19485152
12. Admission of hypertensive patients at the University of Benin Teaching Hospital, Nigeria. Ukoh VA, East Afr Med J 2007 84 329 35 17886427
13. Causes of death at Tshepong, a rural hospital, 1986-1987. Steenekamp JH, Simson IW, van der Merwe CA, S Afr Med J 1989 76 422 6 2799593 (Pubitemid 20003466)
14. Cardiovascular causes of death at Tshepong Hospital in 1 year, 1989-1990. A necropsy study. Steenekamp JH, Simson IW, Theron W, S Afr Med J 1992 81 142 6 1734552
15. The changing pattern of heart disease in South African Blacks. Isaacson C, S Afr Med J 1977 52 793 8 607491 (Pubitemid 8238756)
16. Perspectives on research in hypertension. Seedat YK, Cardiovasc J Afr 2009 20 39 42 19287815
17. Hypertension - in black and white. Lancet 1992 339 28-9 1351552
18. Impact of age, race, and obesity on hypertensive mechanisms and therapy. Weir MR, Am J Med 1991 90 3S 14S 1872302
19. The management of hypertension in the African American patient. Wright JT, Jamerson KA, Ferdinand KC, J Clin Hypertens (Greenwich) 2007 9 468 75 10.1111/j.1524-6175.2007.07151.x
20. Race-based therapeutics. Yancy CW, Curr Hypertens Rep 2008 10 276 85 10.1007/s11906-008-0052-8 18625156
21. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95) 00134-4 8721797 (Pubitemid 26120810)
22. Antihypertensive utility of perindopril in a large, general practice-based clinical trial. Julius S, Cohn JN, Neutel J, Weber M, Turlapaty P, Shen Y, Dong V, Batchelor A, Lagast H, J Clin Hypertens (Greenwich) 2004 6 10 7 10.1111/j.1524-6175.2004.02440.x
23. Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial. Cohn JN, Julius S, Neutel J, Weber M, Turlapaty P, Shen Y, Dong V, Batchelor A, Guo W, Lagast H, Am J Hypertens 2004 17 134 8 10.1016/j.amjhyper.2003.09.017 14751655 (Pubitemid 38125130)
24. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The trandolapril multicenter study group. Weir MR, Gray JM, Paster R, Saunders E, Hypertension 1995 26 124 30 10.1161/01.HYP.26.1.124 7607715
25. Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1. Pahor M, Franse LV, Deitcher SR, Cushman WC, Johnson KC, Shorr RI, Kottke-Marchant K, Tracy RP, Somes GW, Applegate WB, Circulation 2002 105 457 61 10.1161/hc0402.102929 11815428 (Pubitemid 34141702)
26. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol 1982 14 Suppl 2 97S 101S 6753911
27. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. Weinberger MH, J Cardiovasc Pharmacol 1985 7 Suppl 1 52 5 2580177
28. Demography predicts blood pressure response to once-daily enalapril monotherapy of mild to moderate essential hypertensive patients. Thind GS, Am J Hypertens 1988 1 3 Pt 3 227S 229S 10.1093/ajh/1.3.227S 2843196
29. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The department of veterans affairs cooperative study group on antihypertensive agents. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, N Engl J Med 1993 328 914 21 10.1056/NEJM199304013281303 8446138 (Pubitemid 23086643)
30. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension. Chrysant SG, Fagan T, Glazer R, Kriegman A, Arch Fam Med 1996 5 17 24 10.1001/archfami.5.1.17 8542050 (Pubitemid 126445091)
31. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Weir MR, Chrysant SG, McCarron DA, Canossa-Terris M, Cohen JD, Gunter PA, Lewin AJ, Mennella RF, Kirkegaard LW, Hamilton JH, Weinberger MH, Weder AB, Hypertension 1998 31 1088 96 10.1161/01.HYP.31.5.1088 9576119 (Pubitemid 28191502)
32. Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY study group. Weir MR, Reisin E, Falkner B, Hutchinson HG, Sha L, Tuck ML, Am J Hypertens 1998 11 8 Pt 1 914 20 9715782 (Pubitemid 28378403)
33. Determinants of blood pressure response to quinapril in black and white hypertensive patients: the quinapril titration interval management evaluation trial. Mokwe E, Ohmit SE, Nasser SA, Shafi T, Saunders E, Crook E, Dudley A, Flack JM, Hypertension 2004 43 1202 7 10.1161/01.HYP.0000127924.67353.86 15117912 (Pubitemid 38691741)
34. Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population. Van Rijn-Bikker PC, Mairuhu G, van Montfrans GA, Sijbrands EJG, Zwinderman AH, Guchelaar H-J, Koopmans RP, Am J Hypertens 2009 22 1295 302 10.1038/ajh.2009.192 19779464
35. Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. Moran A, Simon JA, Shiboski S, Pickering TG, Waters D, Rotter JI, Lyon C, Nickerson D, Yang H, Saad M, Hsueh W, Krauss RM, Am J Hypertens 2007 20 884 91 10.1016/j.amjhyper.2007.02.006 17679038 (Pubitemid 47179878)
36. Lowering blood pressure for cardiovascular risk reduction. McInnes GT, J Hypertens Suppl 2005 23 3 8 10.1097/01.hjh.0000165622.34192.fd 16106564
37. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Morgan TO, Anderson AI, MacInnis RJ, Am J Hypertens 2001 14 241 7 10.1016/S0895-7061(00)01266-8 11281235 (Pubitemid 32202707)
38. A summary of the effects of antihypertensive medications on measured blood pressure. Wu J, Kraja AT, Oberman A, Lewis CE, Ellison RC, Arnett DK, Heiss G, Lalouel J-M, Turner ST, Hunt SC, Province MA, Rao DC, Am J Hypertens 2005 18 935 42 10.1016/j.amjhyper.2005.01.011 16053990 (Pubitemid 41040264)
39. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FHH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB, JAMA 2005 293 1595 608 10.1001/jama.293.13.1595 15811979 (Pubitemid 40471790)
40. Overlap between whites and blacks in response to antihypertensive drugs. Sehgal AR, Hypertension 2004 43 566 72 10.1161/01.HYP.0000118019.28487.9c 14757779 (Pubitemid 38282429)
41. National Institute for Health and Clinical Excellence, Hypertension: Clinical Management of Primary Hypertension in Adults. CG127 London: National Institute for Health and Care Excellence 2011
42. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, Hypertension 2003 42 1206 52 10.1161/01.HYP.0000107251.49515.c2 14656957 (Pubitemid 37553153)
43. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, JAMA 2002 288 2421 31 10.1001/jama.288.19.2421 12435255 (Pubitemid 35340538)
44. Progress report on the first sub-Saharan trial of newer versus older antihypertensive drugs in native black patients. Odili AN, Ezeala-Adikaibe B, Anisiuba BC, Kamdem MM, Ndiaye MB, Ijoma CK, Kaptue J, Boombhi HJ, Kolo PM, Shu EN, Thijs L, Staessen JA, Omotoso BA, Kingue S, Ba SA, Lemogoum D, M'buyamba-Kabangu J-R, Trials 2012 13 59 10.1186/1745-6215-13-59 22594907